Back to Search

OCUL

Ocular Therapeutix, Inc.
Data: 2026-07-31
$8.17
Price
-3.54%
Change
$16.44
52W High
$6.23
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Quick Stats
Jul 31, 2026

58.0

AI Score

HOLD

0.79

Volume Ratio

Aug 04, 2026

Next Earnings

13

+ve Days (30d)

17

-ve Days (30d)

OCUL Stock Summary

Last updated Jul 31, 2026

OCUL is currently trading at $8.17, positioned below its 200-day moving average of $10.11, suggesting bearish momentum. The stock has a 52-week range of $6.2301 to $16.44.

Technical Analysis: The 50-day moving average stands at $9.09, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 35.295, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.111, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates OCUL at 58.0/100 with a HOLD recommendation.

OCUL (Ocular Therapeutix, Inc.) Indicators

Last updated Jul 31, 2026

Indicator Value
RSI(14) 35.295
CMF (20) -0.111
ROC (10) -8.919
ADX (14) 21.13
Indicator Value
MACD (12,26,9) -0.318
AROONOSC (14) -100.0
WILLAMS %R (14) -98.945
MFI (14) 30.975
OCUL Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

OCUL Price vs Max Options Open Interest
OCUL Max Change In Options Open Interest

OCUL Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

OCUL Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

OCUL Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

OCUL Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Ocular Therapeutix, Inc. is below both the 50 Day and 200 Day SMA which is considered Bearish.

OCUL Moving Averages Analysis

OCUL (Ocular Therapeutix, Inc.) Simple Moving Averages

Moving Averages are last updated Jul 31, 2026

Days MA
10 8.54
20 9.21
30 9.4
50 9.09
100 9.0
200 10.11

OCUL Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 1.9 billion
Earnings/Share ($) -1.46
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -1.582
EPS Estimate Next Year ($) -1.478
WallStreet Target Price ($) 27.09
Most Recent Quarter